Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Thomas focuses genitourinary and gastrointestinal malignancies.
Prior Pluvicto Shortage Led to Long Waiting Lists for Patients With mCRPC
Roby Thomas, MD, discusses the shortage of lutetium Lu 177 vipivotide tetraxetan, and how it had affected patients with metastatic castration-resistant prostate cancer being treated at UPMC Hillman Cancer Center.
Chemotherapy Shortages Trouble Study Investigators
Roby Thomas, MD discusses chemotherapy shortages and the impact these shortages have had on oncology research.
Pluvicto Shortage Regresses Prostate Cancer Care
Roby Thomas, MD, the ongoing shortage of the PSMA-targeted radionuclide therapy, Pluvicto and the impact it is having on prostate cancer care.
Considerations for Oncologists During Chemotherapy Shortages
Roby Thomas, MD, provides ideas for oncologists to consider while multiple chemotherapy drug are on shortage in the United States.
2 Clarke Drive Cranbury, NJ 08512